Home/Filings/4/0001209191-23-001931
4//SEC Filing

Fitzpatrick Alexander A 4

Accession 0001209191-23-001931

CIK 0001671858other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:00 PM ET

Size

5.5 KB

Accession

0001209191-23-001931

Insider Transaction Report

Form 4
Period: 2023-01-03
Fitzpatrick Alexander A
Chief Legal Officer
Transactions
  • Award

    Stock option (right to buy)

    2023-01-03+700,000700,000 total
    Exercise: $8.42Exp: 2033-01-02Common Stock (700,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on December 1, 2023, and the remaining shares will vest monthly thereafter over three years.

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001398595

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:00 PM ET
Size
5.5 KB